China’s embrace of embryo selection raises thorny questions
نویسندگان
چکیده
منابع مشابه
Suspension recalls past cases , raises questions
When the University sent sopho more guard Kyle McAlarney home last Monday, it wasn’t just the bas ketball p lay e r’s nam e th a t got splashed across national h ead lines. The d ec ision to su sp en d McAlarney — who was arrested Dec. 29 on charges of marijuana possession — im m ediately p ro je c te d N otre Dam e in to the debate. “T he bad new s is everyone always looks at cases that ...
متن کاملPopulation aging raises questions for policymakers.
This issue of Asia-Pacific Population and Policy examines the size of the elderly population in Asia and projections for the next 50 years. It discusses some of the characteristics of Asia's elderly population. Information is based on a study of population momentum and population aging at the East-West Center prepared by the UN for the 32 countries in East, Southeast, and South Asia with popu...
متن کاملHuman papillomavirus: every answer raises more questions.
G human papillomavirus (HPV) is the most common sexually transmitted infection worldwide.1 Because it is so prevalent in men and women, is easily transmitted by skin-to-skin contact, and is often asymptomatic and undetectable, it is difficult to effectively prevent transmission despite our best efforts, including promotion of abstinence, condom use, and circumcision.2 This difficulty is very im...
متن کاملStem cell treatments raise thorny questions for researchers, clinicians.
S cientists and clinicians in La Jolla, Calif., at the end of last November, celebrated the grand opening of the 150,000-square-foot Sanford Consortium for Regenerative Medicine (SCRM), a modern, four-story glass-and-metal symbol of the hope for the healing properties of stem cell treatments. Funded in part with a $43 million grant from public funds that created the California Institute for Reg...
متن کاملIncrease in oral cancer drugs raises thorny issues for oncology practices.
T he recent announcement of the prestigious 2009 Lasker clinical research award to the developers of imatinib (Gleevec) recognizes the advent of a new generation of targeted therapies, many of them taken as pills, that have transformed cancer treatment for many patients. In the last 5 – 10 years, oral agents such as gefitinib, erlotinib, lapatinib, and capecit abine have followed imatinib. And ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature
سال: 2017
ISSN: 0028-0836,1476-4687
DOI: 10.1038/548272a